Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the uael domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/imagionbx/wp-includes/functions.php on line 6114

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the kirki domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/imagionbx/wp-includes/functions.php on line 6114
Imagion Biosystems December 2021 Investor Newsletter | Imagion Biosystems
Search
Twitter-square Facebook-square Linkedin Youtube

Imagion Biosystems December 2021 Investor Newsletter

Imagion Biosystems December 2021 Investor Newsletter

We are pleased to provide our investors with our December 2021 Investor Newsletter.

In this edition, our Executive Director and CEO Bob Proulx gives an update on our recent activities, highlighting the progress in our MagSense Phase 1 clinical trial.

You can also read more from the Principal Investigator for our study at Lake Macquarie, an introduction to our new Director of Operations, Carmen Soikowski, and other relevant company news – including a look at our new facility.

We thank you for your continued support of our company and the work we are doing to develop our technology.

Imagion Biosystems normally distributes this update as an e-newsletter. Investors can sign up to receive email updates at this link: http://ems.gs/3FuT0frcGxD

Please click to review the newsletter.

Related Articles

Successful Placement of A$3M

October 10, 2024

Imagion Biosystems (ASX: IBX) (Company), is pleased to announce the Company has received $3 million of firm commitments through a highly successful capital raising. The

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.

Get in touch

About Imagion Biosystems

Imagion Biosystems (IBX) is an innovative medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases.

Contact us

Join our email list

Stay informed about our latest news and developments.

© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance

Twitter-square Facebook-square Linkedin Youtube